<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220209053981N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-02-24</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>The effect of multi-sensory stimuli on dependence on the elderly caregiver</public_title>
      <acronym>MSE</acronym>
      <scientific_title>The Effect Of multi-sensorial Environment (Snoezelen Therapy) On The Care Dependence Of The Elderly With Parkinson Disease.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-02-12</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/61896</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: Sampling is available. Members are then randomized based on blockchain. This method is used to avoid significant imbalances in the number of participants assigned to each group. Block randomization ensures that no significant imbalance is established between groups at any time during randomization, and at certain points the number of participants in each group is equal. For this method, the volume of each block must first be determined.(Example of a quadruple block). Then write a list of blocks and assign numbers to them ((1)AABB  - (2)ABAB  -(3)ABBA  -(4)BBAA  -(5) BABA  -(6) BAAB ) Then select random numbers between one and 6 (Eg 1 4 5, etc.) and finally specify the treatment allocation list based on previous random numbers (AB AABB-BBAA-BABA-).
The method of four random blocks (AABB, ABAB, BBAA, BABA,) which have been prepared using the Randomization site will be used to assign research units to two groups. The blocks will be prepared before sampling begins. Random sequences will be stored in closed-door envelopes until sampling, Blinding description: In this study, participants were randomly grouped and blinded. Participants become blind, so that people have no knowledge of the group to which they are assigned.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Parkinson's disease.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: After determining the research units and preparing the snow room, the researcher will be fully acquainted with the snow room, the available equipment and how they work. After the researcher is fully acquainted with snozlen, the patients of the intervention group will be present in the hospital environment after coordination on the days of periodic visits or with the coordination and request of the patient. Patients then enter the room in groups of three. Preparations before starting Snoozelen: To reduce distraction and focus more, the cell phone should not be used in the room environment and we ask participants to turn off their cell phones and if they need a hygienic service or may be in If they need a session, be sure to go before starting the intervention.Before starting, we explain the snoozelen steps to the participants and answer any questions we may have, as well as reassuring them that they can leave the room whenever they want, thus showing them that they are completely on the environment. They have control. Now the intervention of snozlen begins. The olfactory stimulant of essential oil (5 drops of mint and one to two drops of water from Nicochemical Company) We spread the essential oil burning device in the environment and ask the participants to close their eyes and take four breaths 1-4-2 (2 seconds of inhalation). , 4 seconds of respiratory arrest, 1 second of exhalation) to reduce anxiety. Then we play the visual and auditory stimulus (a relaxing clip selected in consultation with a neurologist). During the broadcast, the researcher pays attention to each person's reaction and is recorded in the researcher's observation checklist (for example, the clip of the first session fascinated or disliked participant A). Thus, receiving 25 minutes of stimuli and the last 5 minutes of auditory and visual stimuli are turned off and the participant focuses again on the olfactory stimulus, and we ask the patient to breathe 1-4-2 again and to express his opinion and expectations. Tell the first session. Finally, we thank the participants and end the meeting. Each session provides them with different visual and auditory stimuli. After 8 sessions, the care dependency questionnaire is completed again. Intervention 2: Control group:  Members of this group receive standard care only under the supervision of their physician and complete the care dependency questionnaire scale twice in 8 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Yousefli</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery Mashhad, Ebn Sina St., Doctora Blvd.</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9197968280</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>farnazyousefli98@gmail.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Najmeh Valizade</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwiffery, Ebn Sina Ave., Doctora Blvd.</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>valizadehn@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Elderly desire to participate in the study
Elderly people over 60 with Parkinson's in the first and second stages
Lack of cognitive problems with MMSE tools
Absence of severe disturbances in the senses of smell, sight and hearing in the examination
No active mental illness</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Reluctance to participate in further study
Participant's death
Absence from 1 session out of 8 sessions of Snoezelen therapy
Change the disease stage to end stage
Incidence of cognitive impairment
Activation of mental disorder</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G20</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Parkinson's disease</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: After determining the research units and preparing the snow room, the researcher will be fully acquainted with the snow room, the available equipment and how they work. After the researcher is fully acquainted with snozlen, the patients of the intervention group will be present in the hospital environment after coordination on the days of periodic visits or with the coordination and request of the patient. Patients then enter the room in groups of three. Preparations before starting Snoozelen: To reduce distraction and focus more, the cell phone should not be used in the room environment and we ask participants to turn off their cell phones and if they need a hygienic service or may be in If they need a session, be sure to go before starting the intervention.Before starting, we explain the snoozelen steps to the participants and answer any questions we may have, as well as reassuring them that they can leave the room whenever they want, thus showing them that they are completely on the environment. They have control. Now the intervention of snozlen begins. The olfactory stimulant of essential oil (5 drops of mint and one to two drops of water from Nicochemical Company) We spread the essential oil burning device in the environment and ask the participants to close their eyes and take four breaths 1-4-2 (2 seconds of inhalation). , 4 seconds of respiratory arrest, 1 second of exhalation) to reduce anxiety. Then we play the visual and auditory stimulus (a relaxing clip selected in consultation with a neurologist). During the broadcast, the researcher pays attention to each person's reaction and is recorded in the researcher's observation checklist (for example, the clip of the first session fascinated or disliked participant A). Thus, receiving 25 minutes of stimuli and the last 5 minutes of auditory and visual stimuli are turned off and the participant focuses again on the olfactory stimulus, and we ask the patient to breathe 1-4-2 again and to express his opinion and expectations. Tell the first session. Finally, we thank the participants and end the meeting. Each session provides them with different visual and auditory stimuli. After 8 sessions, the care dependency questionnaire is completed again.</i_keyword>
      <i_keyword>Control group:  Members of this group receive standard care only under the supervision of their physician and complete the care dependency questionnaire scale twice in 8 weeks.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Care dependency score changes. Timepoint: At the beginning of the study before the intervention and after 8 sessions (8 weeks). Method of measurement: Care Dependence Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-02-10</approval_date>
        <contact_name>Ethical commitee of Mashhad University of medical science</contact_name>
        <contact_address>Faculty of Nursing and Midwifery Mashhad, Ebn Sina St., Doctora Blvd.. Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
